The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery
Abstract
The aim of the present study was to develop single dose delivery systems based on nanotechnology for prolonged antibiotic release in a controlled manner. Five different drug–carrier ratios of ciprofloxacin hydrochloride‐loaded nanoparticles of albumin, gelatin, chitosan (CS), and lipid [solid lipid nanoparticles (SLNs)] were prepared and characterized. Average particle size was found to be in the range of 73 ± 2 to 98 ± 44 nm for SLNs, 140 ± 7 to 175 ± 24 nm for albumin nanoparticles, 143 ± 18 to 184 ± 27 nm for gelatin nanoparticles, and 247 ± 48 to 322 ± 52 nm for CS nanoparticles. A drug‐to‐carrier ratio of 0.5:1 was preferred for CS nanoparticles having zeta potential of >20 mV and drug encapsulation of 35.01% ± 2.66%. Similarly, 0.6:1 ratio was preferred for albumin nanoparticles with zeta potential >16 mV and drug encapsulation 48.20% ± 3.01%. Zeta potentials of gelatin nanoparticles loaded with ciprofloxacin suggested that they were unstable and prone to flocculation. SLN with 0.25:1 drug carrier ratio showed 38.71% ± 2.38% drug entrapment and −28 ± 1 mV surface charge. All the nanoparticles showed sustained drug release avoiding “burst effect” of the free drugs for up to 120 h for albumin nanoparticles, 96 h for CS and gelatin nanoparticles, and 80 h for SLNs. The drug release profiles followed Higuchi model. Results suggest that CS nanoparticles and SLNs can act as promising carriers for sustained ciprofloxacin release in infective conditions. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Jain et al. used different nanocarriers for ciprofloxacin encapsulation and showed that SLNs were able to promote a prolonged drug release.215”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
In the citing paper
“Apart from ciprofloxacin, SLNs were also capable of loading other anti-TB drugs, such as rifabutin, INH, RIF, and PZA.215”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
In the citing paper
“Jain and Banerjee also demonstrated the sustained release of ciprofloxacin (up to 80 h).215”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
In the citing paper
“SLNs have been extensively used in formulations for the delivery of anti-TB drugs.”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
Citations
Cites
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., & Schubert, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00134-0 · Cited by 760
Desolvation process and surface characterisation of protein nanoparticles
Weber, C., Coester, C., Kreuter, J., & Langer, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00370-1 · Cited by 605
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Preparation and characterization of chitosan microparticles intended for controlled drug delivery
Ko, J. A., Park, H. J., Hwang, S., Park, J. B., & Lee, J. S. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00487-8 · Cited by 462
Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles
Banerjee, T., Mitra, S., Singh, A. K., Sharma, R. K., & Maitra, A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00267-3 · Cited by 409
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration
Wissing, S. A., & Müller, R. H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00056-1 · Cited by 405
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 368
Nanomedicines for overcoming biological barriers
Alonso, M. J. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Research works printed but not linked: 2
- Coester C, 2006, In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localization, Eur J Pharm Sci, 62, 306
- Utreja S, 2001, Advances in Controlled and Novel Drug Delivery, 408
Cited by
Sorted by citations
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,920
Polysaccharides-based nanoparticles as drug delivery systems
Liu, Z., Jiao, Y., Wang, Y., Zhou, C., & Zhang, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.001 · Cited by 1,739
Albumin-based nanoparticles as potential controlled release drug delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.031 · Cited by 1,526
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
Elzoghby, A. O. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.019 · Cited by 657
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Nanoparticles: Emerging carriers for drug delivery
Mudshinge, S. R., Deore, A. B., Patil, S. R., & Bhalgat, C. M. (2011) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2011.04.001 · Cited by 557
Nanomedicine in the management of microbial infection – Overview and perspectives
Zhu, X., Radovic‐Moreno, A. F., Wu, J., Langer, R., & Shi, J. (2014) · Nano Today · doi:10.1016/j.nantod.2014.06.003 · Cited by 364
Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery
Parveen, S., & Sahoo, S. K. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.023 · Cited by 302
Sharifi-Rad, J., Quispe, C., Butnariu, M., Rotariu, L. S., Sytar, O., Sestito, S., Rapposelli, S., Akram, M., Iqbal, M., Krishna, A., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02025-4 · Cited by 290
Preparation and application of micro/nanoparticles based on natural polysaccharides
Yang, J., Han, S., Zheng, H., Dong, H., & Liu, J. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.01.029 · Cited by 277
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 273
Insight on the Formation of Chitosan Nanoparticles through Ionotropic Gelation with Tripolyphosphate
Koukaras, E. Ν., Papadimitriou, S. A., Bikiaris, D. Ν., & Froudakis, G. E. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300162j · Cited by 257
Jiang, Q., Reddy, N., & Yang, Y. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.04.024 · Cited by 221
Nanoengineered Drug Delivery Systems for Enhancing Antibiotic Therapy
Kalhapure, R. S., Suleman, N., Mocktar, C., Seedat, N., & Govender, T. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24298 · Cited by 217
Advances in using chitosan-based nanoparticles forin vitroandin vivodrug and gene delivery
Duceppe, N., & Tabrizian, M. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.514604 · Cited by 205
Hybrid fluorescent curcumin loaded zein electrospun nanofibrous scaffold for biomedical applications
Dhandayuthapani, B., Mathew, A., Girija, A. R., Nagaoka, Y., Venugopal, K., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Biomedical Materials · doi:10.1088/1748-6041/7/4/045001 · Cited by 188
Chaudhury, A., & Das, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9561-2 · Cited by 174
Nanoparticles of Chitosan Loaded Ciprofloxacin: Fabrication and Antimicrobial Activity
Sobhani, Z., Mohammadi‐Samani, S., Montaseri, H., & Khezri, E. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.051 · Cited by 159
Zein/cellulose acetate hybrid nanofibers: Electrospinning and characterization
Ali, S., Khatri, Z., Oh, K. W., Kim, I. S., & Kim, S. H. (2014) · Macromolecular Research · doi:10.1007/s13233-014-2136-4 · Cited by 151
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123
Tran, C. D., Duri, S., Delneri, A., & Franko, M. (2013) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2013.02.046 · Cited by 121
Harkins, A. L., Duri, S., Kloth, L. C., & Tran, C. D. (2014) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33103 · Cited by 110
Yılmaz, A., Bozkurt, F., Cicek, P. K., Dertli̇, E., Durak, M. Z., & Yılmaz, M. T. (2016) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2016.08.008 · Cited by 110
Sohail, R., & Abbas, S. R. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.191 · Cited by 107
Ionically Crosslinked Chitosan Membranes Used as Drug Carriers for Cancer Therapy Application
Tomaz, A. F., de Carvalho, S. M. S., Barbosa, R. C., Silva, S. M. D. L., Gutierrez, M. A. S., de Lima, A. G. B., & Fook, M. V. L. (2018) · Materials · doi:10.3390/ma11102051 · Cited by 105
Mututuvari, T. M., & Tran, C. D. (2013) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2013.11.007 · Cited by 97
Nano-technology for targeted drug delivery to combat antibiotic resistance
Sharma, A., Arya, D. K., Dua, M., Chhatwal, G. S., & Johri, A. K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.717927 · Cited by 94
Chitosan nanoparticles loaded antibiotics as drug delivery biomaterial
Ibrahim, H., El-Bisi, M. K., Taha, G. M., & El-Alfy, E. A. (2015) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2015.501015 · Cited by 94
Souto, E. B., & Doktorovová, S. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)64006-4 · Cited by 94
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Velino, C., Carella, F., Adamiano, A., Sanguinetti, M., Vitali, A., Catalucci, D., Bugli, F., & Iafisco, M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00406 · Cited by 98
Mosaiab, T., Farr, D. C., Kiefel, M. J., & Houston, T. A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.09.002 · Cited by 93
Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article
Matalqah, S. M., Aiedeh, K., Mhaidat, N. M., Alzoubi, K. H., Bustanji, Y. K., & Hamad, I. M. (2020) · Current Drug Targets · doi:10.2174/1389450121666200711172536 · Cited by 100
Cockle Shell-Derived Calcium Carbonate (Aragonite) Nanoparticles: A Dynamite to Nanomedicine
Mailafiya, M. M., Abubakar, K., Danmaigoro, A., Chiroma, S. M., Rahim, E. B. A., Moklas, M. A. M., & Zakaria, Z. A. B. (2019) · Applied Sciences · doi:10.3390/app9142897 · Cited by 89
Khan, M. A., Zafaryab, M., Mehdi, S. H., Quadri, J. A., & Rizvi, M. M. A. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.12.090 · Cited by 87
Development of polyvinyl alcohol–gelatin membranes for antibiotic delivery in the eye
Jain, D., Carvalho, E. J., Banthia, A. K., & Banerjee, R. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.502533 · Cited by 84
Self-citationBiodegradable hybrid polymeric membranes for ocular drug delivery
Jain, D., Carvalho, E. J., & Banerjee, R. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.11.001 · Cited by 82
Self-citationShehabeldine, A. M., & Hasanin, M. S. (2019) · Environmental Nanotechnology Monitoring & Management · doi:10.1016/j.enmm.2019.100252 · Cited by 76
Ismail, S. A., El-Sayed, H. S., & Fayed, B. E. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.115941 · Cited by 76
Tran, C. D., & Mututuvari, T. M. (2016) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.6b00084 · Cited by 78
Trif, E., Cerbu, C. G., Olah, D. I., Zăblău, S. D., Spînu, M., Potărniche, A.-V., Páll, E., & Brudaşcă, F. (2023) · Animals · doi:10.3390/ani13101695 · Cited by 65
Kumar, G. V., Su, C., & Velusamy, P. (2016) · Materials Letters · doi:10.1016/j.matlet.2016.05.108 · Cited by 61
Mututuvari, T. M., Harkins, A. L., & Tran, C. D. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34636 · Cited by 59
Pignatello, R., Leonardi, A., Fuochi, V., Petronio, G. P., Greco, A. S., & Furneri, P. M. (2018) · Nanomaterials · doi:10.3390/nano8050304 · Cited by 60
Parveen, S., Mitra, M., Krishnakumar, S., & Sahoo, S. K. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.02.010 · Cited by 61
RetractedSruthi, R., Balagangadharan, K., & Selvamurugan, N. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111110 · Cited by 58
Satari, N., Taymouri, S., Varshosaz, J., Rostami, M. R., & Mirian, M. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1788063 · Cited by 56
Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes
Yayehrad, A. T., Wondie, G. B., & Marew, T. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s348643 · Cited by 55
Spherical nanocomposite particles prepared from mixed cellulose–chitosan solutions
Yang, J., Duan, J., Zhang, L., Lindman, B., Edlund, H., & Norgren, M. (2016) · Cellulose · doi:10.1007/s10570-016-1029-4 · Cited by 54
Ahmadi, M., & Adibhesami, M. (2017) · Europe PMC (PubMed Central) · Cited by 53
Hussain, A., Singh, S., Das, S. S., AnjiReddy, K., Karpagam, S., & Shakeel, F. (2019) · Current Drug Delivery · doi:10.2174/1567201816666190201144815 · Cited by 52
Cho, E., & Jung, S. (2015) · Molecules · doi:10.3390/molecules201019620 · Cited by 50
Isa, T., Zakaria, Z., Rukayadi, Y., Noor, M. H. M., Jaji, A. Z., Imam, M. U., Hammadi, N. I., & Mahmood, S. K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050713 · Cited by 50
Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
López‐López, M., Fernández-Delgado, A., Moyá, M. L., Blanco-Arévalo, D., Sánchez, C. C., de la Haba, R. R., Ventosa, A., Bernal, E., & López‐Cornejo, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020057 · Cited by 50
Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus
Ghaderkhani, J., Yousefimashouf, R., Arabestani, M. R., Roshanaei, G., Asl, S. S., & Abbasalipourkabir, R. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1593858 · Cited by 49
Tran, C. D., Duri, S., & Harkins, A. L. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34520 · Cited by 48
Das, B., & Patra, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46152-8.00001-9 · Cited by 43
Ghaffari, S., Varshosaz, J., Haririan, I., Khoshayand, M. R., Azarmi, S., & Gazori, T. (2012) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2011.579831 · Cited by 40
Duri, S., & Tran, C. D. (2013) · Langmuir · doi:10.1021/la3050016 · Cited by 40
Farhangi, M. A., Mahboubi, A., Kobarfard, F., Vatanara, A., & Mortazavi, S. A. (2018) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2018.1545237 · Cited by 39
Mailafiya, M. M., Abubakar, K., Danmaigoro, A., Chiroma, S. M., Rahim, E. B. A., Moklas, M. A. M., & Zakaria, Z. A. B. (2019) · Biomedical Research and Therapy · doi:10.15419/bmrat.v6i12.580 · Cited by 38
Soliman, N. M., Shakeel, F., Haq, N., Alanazi, F. K., Alshehri, S., Bayomi, M. A., Alenazi, A. S. M., & Alsarra, I. A. (2022) · Molecules · doi:10.3390/molecules27144468 · Cited by 37
Li, J.-J., Chen, T., Deng, F., Wan, J., Tang, Y.-L., Yuan, P., & Zhang, L.-K. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s88253 · Cited by 36
Farhangi, M. A., Kobarfard, F., Mahboubi, A., Vatanara, A., & Mortazavi, S. A. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1442847 · Cited by 36
pH-responsive magnetic biocompatible chitosan-based nanocomposite carrier for ciprofloxacin release
Jabbari, P., Mahdavinia, G. R., Rezaei, P. F., Kazemi, B., Labib, P., Jafari, H., & Javanshir, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126228 · Cited by 35
Yıldırım, M., Poyraz, S., Acet, Ö., Acet, B. Ö., Karakoç, V., & Odabaşı, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144367 · Cited by 34
Almurshedi, A. S., Aljunaidel, H. A., AlQuadeib, B. T., Aldosari, B. N., Alfaqiah, I. M., Almarshidy, S. S., Eltahir, E., & Mohamoud, A. Z. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s286896 · Cited by 34
Anand, T., Muniyandi, A., Thomas, P. A., & Geraldine, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102696 · Cited by 37
Dhanalakshmi, V., Nimal, T. R., Sabitha, M., Biswas, R., & Jayakumar, R. (2016) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33635 · Cited by 35
Taymouri, S., Shahnamnia, S., Mesripour, A., & Varshosaz, J. (2021) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2021.1948571 · Cited by 33
Development of chitosan-graphene oxide blend nanoparticles for controlled flurbiprofen delivery
Erol, Ü. H., Güncüm, E., & Işıklan, N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125627 · Cited by 31
Initial Observations of Cell-Mediated Drug Delivery to the Deep Lung
Kumar, A. B., Glaum, M. C., El‐Badri, N., Mohapatra, S. S., Haller, E. M., Park, S., Patrick, L., Nattkemper, L. A., Vo, D., & Cameron, D. F. (2010) · Cell Transplantation · doi:10.3727/096368910x536491 · Cited by 30
Noorani, M., Azarpira, N., Karimian, K., & Heli, H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.102 · Cited by 29
Kolluru, L. P., Chandran, T., Shastri, P. N., Rizvi, S. A. A., & D’Souza, M. J. (2020) · Journal of Nanoparticle Research · doi:10.1007/s11051-020-05096-y · Cited by 29
Nano-engineering chitosan particles to sustain the release of promethazine from orodispersables
Elwerfalli, A. M., Al-Kinani, A. A., Alany, R. G., & ElShaer, A. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.05.064 · Cited by 28
Transdermal microneedle-mediated delivery of polymeric lamivudine-loaded nanoparticles
Ramadan, E., Borg, T., Abdelghani, G. M., & Saleh, N. M. (2016) · journal of Pharmaceutical Technology and Drug Research · doi:10.7243/2050-120x-5-1 · Cited by 26
Makhmalzadeh, B. S., Esfahani, G., & Salimi, A. (2018) · Molecules · doi:10.3390/molecules23081904 · Cited by 27
Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity
Reighard, K. P., Ehré, C., Rushton, Z. L., Ahonen, M. J. R., Hill, D. B., & Schoenfisch, M. H. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00039 · Cited by 27
BioPerine Encapsulated Nanoformulation for Overcoming Drug-Resistant Breast Cancers
Pillai, S. C., Borah, A., Jindal, A., Jacob, E. M., Yamamoto, Y. Y., & Kumar, D. S. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.04.001 · Cited by 25
Ovomucin nanoparticles: promising carriers for mucosal delivery of drugs and bioactive compounds
Akbari, A., & Wu, J. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0406-3 · Cited by 25
Drug delivery systems for fluoroquinolones: New prospects in tuberculosis treatment
Le‐Deygen, I. M., Скуредина, А. А., & Kudryashova, E. V. (2017) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162017050077 · Cited by 24
Advancements in Nanoparticle-Based Strategies for Enhanced Antibacterial Interventions
Moradialvand, M., Asri, N., Jahdkaran, M., Beladi, M., & Houri, H. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01428-0 · Cited by 23
Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention
Garg, P., Venuganti, V. V. K., Roy, A., & Roy, G. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1690451 · Cited by 23
Polysaccharide-Based Nanoparticles as Drug Delivery Systems
Vavilala, S. L., & D’Souza, J. S. (2016) · CRC Press eBooks · doi:10.1201/9781315372303-32 · Cited by 23
Zhou, Y., Jia, X., Tan, L., Xie, Q., Lei, L., & Yao, S. (2009) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2009.09.035 · Cited by 22
Cytocompatible and water‐stable camelina protein films for tissue engineering
Zhao, Y. Y., Jiang, Q., Xu, H., Reddy, N., Xu, L. B., & Yang, Y. (2013) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33053 · Cited by 21
Yadav, L. R., Balagangadharan, K., Lavanya, K., & Selvamurugan, N. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120559 · Cited by 21
Current state of the polymeric delivery systems of fluoroquinolones – A review
Mulas, K., Stefanowicz, Z., Olędzka, E., & Sobczak, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.021 · Cited by 21
Jahura, F. T., Ferdousi, F. K., Kamal, A. H. M., Ul‐Hamid, A., Ehsan, M. Q., & Hossain, M. A. (2024) · Nanoscale Advances · doi:10.1039/d4na00548a · Cited by 19
Cherif, N. F., Constantino, V. R. L., Hamdaoui, O., Leroux, F., & Taviot‐Guého, C. (2020) · New Journal of Chemistry · doi:10.1039/d0nj00045k · Cited by 19
Nanocarriers and Their Potential Application as Antimicrobial Drug Delivery
Devrim, B., & Bozkır, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46152-8.00007-x · Cited by 18
María, A., Barbassa, L., & de Melo, L. D. (2011) · InTech eBooks · doi:10.5772/14400 · Cited by 18
CHITOSAN NANOPARTICLES AND THEIR APPLICATIONS IN DRUG DELIVERY: A REVIEW
Najafi, S., Pazhouhnia, Z., Ahmadi, O., Berenjian, A., & Jafarizadeh‐Malmiri, H. (2014) · Current Research in Drug Discovery · doi:10.3844/crddsp.2014.17.25 · Cited by 17
Enantiomeric Selective Adsorption of Amino Acid by Polysaccharide Composite Materials
Duri, S., & Tran, C. D. (2013) · Langmuir · doi:10.1021/la404003t · Cited by 17
Recent advancements and perspective of ciprofloxacin-based antimicrobial polymers
Kanth, S. M., Puttaiahgowda, Y. M., Gupta, S., & Thottathil, S. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2145872 · Cited by 16
Booysen, E., Bezuidenhout, M. B., Staden, A. D. P. V., Dimitrov, D., Deane, S. M., & Dicks, L. M. T. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9437-4 · Cited by 16
Novel nanoparticle materials for drug/food delivery-polysaccharides
Chen, L., Liu, X., & Wong, K.-H. (2016) · Physical Sciences Reviews · doi:10.1515/psr-2016-0053 · Cited by 14
Chitosan for the delivery of antibiotics
Harris, M. A., Alexander, C., Wells, C. M., Bumgardner, J. D., Carpenter, D. P., & Jennings, J. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100228-5.00006-7 · Cited by 14
Polysaccharide nanoparticles for cancer drug targeting
Zhu, Y., Liu, Y., Jin, K., & Pang, Z. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102553-6.00013-1 · Cited by 14
Polysaccharide-Based Nanoparticles as Drug Delivery Systems
Dsouza, V. (2016) · CRC Press eBooks · doi:10.1201/9781315372303-52 · Cited by 14
APPLICATION OF NANOSTRUCTURES IN ANTIMICROBIAL THERAPY
Joshi, M., Lata, S., Preeti, K., & Mishra, T. (2018) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2018v10i4.25803 · Cited by 14
Metadata
- Authors
- Jain, D., & Banerjee, R.
- Affiliations
- Indian Institute of Technology Bombay (IN)
- Corresponding author
- Banerjee, R.
- Venue
- Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Publisher
- Wiley
- Published
- 2007-12-20
- Volume
- 86B
- Issue
- 1
- Pages
- 105-112
- ISSN
- 1552-4973 (ISSN-L)
- 1552-4981
- OpenAlex
- W2074420216
- Cited by
- 158
- References
- 34
- Citations by year
- 2025: 6 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 15 · 2018: 12 · 2017: 18 · 2016: 15 · 2015: 7 · 2014: 5 · 2013: 11 · 2012: 4
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Biomedical Materials Research Part B Applied Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- DSpace (IIT Bombay) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- ciprofloxacin hydrochloride, chitosan nanoparticles, solid lipid nanoparticles, albumin nanoparticles, gelatin nanoparticles, sustained drug release, encapsulation efficiency, zeta potential, Higuchi model, burst release, nanoparticle stability
- MeSH terms
- Albumins, Animals, Cattle, Ciprofloxacin, Drug Carriers, Gelatin, Lipids, Particle Size, Polymers, Scattering, Radiation, Serum Albumin, Drug Delivery Systems, Nanotechnology, Chitosan, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review